Company Profile
Updated: 18-DEC-09Alta Health Products Inc.
Private Company, Headquarters Location
300 Main St., Boise, ID 83702, United States
(800)423-4155, (208)367-1988, (208)367-0089 fax, http://www.altahealthproducts.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Pharmaceutical Preparations
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
United States : City approves loans, payments for roadwork.
TendersInfo; 12/11/2009; 683 words; ...schools, higher education, health-care organizations and private...consumption of nonrenewable products, more efficient water usages...000 agreement with a Pfizer Inc. subsidiary for the company...Boulevard from Kilgore Road to Alta Vista Avenue. Nearly 70 percent...
Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox.
PR Newswire; 11/6/2009; 992 words; ...recent uses of the product under Emergency Investigational...international public health and transplant communities...National Institutes of Health (NIH) to support...States Department of Health and Human Services...Chimerix Chimerix, Inc., is developing...Canaan Partners, Alta ...
Metabolex Closes $8.6 Million Financing Round.
PR Newswire; 11/5/2009; 837 words; ...Metabolex, Inc., a biopharmaceutical...financing include: Alta Partners, Venrock...continue to advance our product portfolio including...Diabetes is a worldwide health problem and a rapidly...illness, death and health care costs. According...Ortho-McNeil, Inc. has the exclusive...
AGY Therapeutics Series C: $31.3M For Three Programs.
BIOWORLD Today; 11/4/2009; 1103 words; ...Editor AGY Therapeutics Inc. netted $31.3 million...predicting it will have a product ready for the clinic...was led by Bear Stearns Health Innoventures, of New...of Antwerp, Belgium; Alta Partners, of San Francisco...partner of Bear Stearns Health Innoventures, and Jack...
Corgentech Series C Raises $50M For Bypass Research.
BIOWORLD Today; 11/4/2009; 969 words; ...West Coast Editor With a product in one Phase III trial...surgery, Corgentech Inc. took an infusion of...financial officer. The product is the E2F Decoy, a...was led by Bear Stearns Health Innoventures LP, of...Zurich, Switzerland; Alta Partners, of San Francisco...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning